UMGCC Paul Calabresi Clinical Oncology Training Program

描述(由申请人提供)：马里兰大学Marlene and Stewart Greenebaum癌症中心(UMGCC)Paul Calabresi临床肿瘤学培训计划将支持Calabresi学者在临床肿瘤学转化研究方面的职业发展和培训。UMGCC Calabresi学者将拥有医学博士、法学博士或同等临床学位，已完成临床培训，并为初级教师职位做好准备。此外，拥有博士学位的博士、药学博士或具有博士学位、拥有至少一次博士后经验并致力于临床肿瘤学转化性研究的博士、药学博士或注册护士也有资格。UMGCC学者计划将推动的主题反映了UMGCC的优势领域：癌症的多模式治疗战略；药物发现和开发；以及在服务不足的少数群体中进行癌症临床研究。该计划将提供临床研究理学硕士学位的教学经验；临床研究经验，重点是每位学者开发与癌症治疗相关的临床试验，以回答基于假设的临床研究问题和翻译终点；以及基础/人口科学活动，将与临床方案翻译问题捆绑在一起。每个学者都有一个由临床导师、基础/人口学导师和生物统计学导师组成的导师委员会，以协助他们实现这些目标。此外，每个奖学金获得者将成立一个独立的资助申请发展委员会，与奖学金获得者导师委员会无关，以促进奖学金获得者获得独立的、同行评审的资助。UMGCC计划的特点包括：1)来自巴尔的摩马里兰大学六所专业学校(UMB医学院、药学、护理、牙科、法律和新成立的UMB公共卫生学院)的参与和支持；2)经验丰富、资金充足的多学科导师；3)UMS现有K30临床研究课程用于卡拉布雷西学者的教学培训；4)与现有K12密切协调和共享资源，特别是UM多学科临床研究职业发展奖；5)由150项开放和累积的临床试验组成的临床研究基地，反映了多学科临床专业知识和机构对支持临床研究的承诺。

DESCRIPTION (provided by applicant): The University of Maryland Marlene and Stewart Greenebaum Cancer Center (UMGCC) Paul Calabresi Clinical Oncology Training Program will support career development and training of Calabresi Scholars in clinical oncology translational research. UMGCC Calabresi Scholars will have an M.D., D.O., or equivalent clinical degree, have finished clinical training, and be ready for a junior faculty appointment. In addition, Ph.D.s, Pharm.D.s, or R.N.s with a Ph.D. who have finished at least one post-doctoral experience and who are committing to a career in clinical oncology translational research are eligible. The themes to be promoted in the UMGCC Scholars Program reflect areas of UMGCC strength: multimodality treatment strategies for cancer; drug discovery and development; and clinical cancer research in underserved minority populations. The Program will provide a didactic learning experience leading to a Master of Science in Clinical Research; a clinical research experience that will focus each Scholar's development of a cancer therapy - related clinical trial to answer a hypothesis-based clinical research question with translational endpoints; and a basic/population science activity which will tie to the clinical protocol translational question. The Scholars will be assisted in these goals by each Scholar having a Mentorship Committee consisting of a Clinical Mentor, a Basic/Population Science Mentor, and a Biostatistical Mentor. In addition, an independent Grant Application Development Committee will be formed for each Scholar, unrelated to the Scholar's Mentor Committee, to promote success of the Scholar in securing independent, peer reviewed funding. The UMGCC Program is distinguished by a number of features including 1) participation and support from six professional Schools at the University of Maryland, Baltimore (UMB Schools of Medicine, Pharmacy, Nursing, Dental, Law and the newly formed UMB School of Public Health); 2) experienced, well-funded multidisciplinary mentors; 3) the strength of UMs existing K30 Clinical Research Curriculum for the Calabresi Scholars' didactic training; 4) close coordination and the sharing of resources with existing K12s, particularly the UM Multidisciplinary Clinical Research Career Development Award; 5) a clinical research base consisting of >150 open and accruing clinical trials reflecting multidisciplinary clinical expertise and Institutional commitment to support clinical research.